WO1990007321A3 - Lymphocyte receptor homing sequences and their uses - Google Patents
Lymphocyte receptor homing sequences and their uses Download PDFInfo
- Publication number
- WO1990007321A3 WO1990007321A3 PCT/US1989/005067 US8905067W WO9007321A3 WO 1990007321 A3 WO1990007321 A3 WO 1990007321A3 US 8905067 W US8905067 W US 8905067W WO 9007321 A3 WO9007321 A3 WO 9007321A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- homing
- proteins
- lymphocyte receptor
- homing sequences
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28920188A | 1988-12-23 | 1988-12-23 | |
US289,201 | 1988-12-23 | ||
US31573689A | 1989-02-24 | 1989-02-24 | |
US315,736 | 1989-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1990007321A2 WO1990007321A2 (en) | 1990-07-12 |
WO1990007321A3 true WO1990007321A3 (en) | 2010-05-27 |
Family
ID=26965504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/005067 WO1990007321A2 (en) | 1988-12-23 | 1989-11-10 | Lymphocyte receptor homing sequences and their uses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0462111A4 (en) |
JP (1) | JPH04504501A (en) |
WO (1) | WO1990007321A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776775A (en) * | 1989-02-21 | 1998-07-07 | Dana-Farber Cancer Institute | Anti-LAM 1-3 antibody and hybridoma |
US7238668B1 (en) | 1989-09-01 | 2007-07-03 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof |
US6551593B1 (en) | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
US7803904B2 (en) | 1995-09-01 | 2010-09-28 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressing and uses thereof |
US7750137B2 (en) | 1995-09-01 | 2010-07-06 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressins |
US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
US6111090A (en) * | 1996-08-16 | 2000-08-29 | Schering Corporation | Mammalian cell surface antigens; related reagents |
CN103212071B (en) * | 2005-08-25 | 2017-12-12 | 亚利桑那大学董事会 | Stem cell fusion model of carcinogenesis |
UA116189C2 (en) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | FORMULATION FOR ANTI-α4β7 ANTIBODY |
EA032625B1 (en) | 2011-05-02 | 2019-06-28 | Милленниум Фармасьютикалз, Инк. | FORMULATION FOR ANTI-α4β7 ANTIBODY |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3852236T2 (en) * | 1987-08-11 | 1995-04-06 | Univ Leland Stanford Junior | Procedure for controlling leukocyte extravasation. |
-
1989
- 1989-11-10 EP EP19900902104 patent/EP0462111A4/en not_active Withdrawn
- 1989-11-10 JP JP2502783A patent/JPH04504501A/en active Pending
- 1989-11-10 WO PCT/US1989/005067 patent/WO1990007321A2/en active Search and Examination
Non-Patent Citations (21)
Also Published As
Publication number | Publication date |
---|---|
EP0462111A4 (en) | 1992-07-08 |
JPH04504501A (en) | 1992-08-13 |
EP0462111A1 (en) | 1991-12-27 |
WO1990007321A2 (en) | 1990-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2790292A (en) | Viral recombinant vectors for expression in muscle cells | |
EP1923467A3 (en) | Adenovirus vectors for gene therapy | |
IT8223795A0 (en) | GAMMA), ITS VEHICLES OF POLYPEPTIDES CONTAINING THE EXPRESSION SEQUENCE, THEIR PROCEDURE OF INTERFERON AMINO ACIDS PREPARATION, HUMAN IMMUNE COMPOSITIONS (HUMAN INTERFERON PHARMACEUTICALS CONTAINING SUCH POLYPEPTIDES. | |
FI854604A0 (en) | Use of oncostatin-A in diagnostic procedure | |
AU5914590A (en) | Muteins of human erythropoietin, the preparation thereof and the use thereof | |
ATE183514T1 (en) | HUMAN PROTEIN P53 PEPTIDES FOR USE IN HUMAN CYTOTOXIC T CELL RESPONSE-INDUCING COMPOSITIONS AND HUMAN P53 PROTEIN SPECIFIC T LYMPHOCYTES | |
SG108208A1 (en) | Connective tissue growth factor | |
NZ306653A (en) | Isolated dna il-17 receptors | |
EP1005540A4 (en) | Ikk-beta proteins, nucleic acids and methods | |
WO1987002697A1 (en) | Supercritical fluid extraction of animal derived materials | |
BR0014087A (en) | Stable Carotene - Xanthophyll Pearl Compositions and Methods of Use | |
HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
ATE177757T1 (en) | IMPROVED IMMUNOGENIC COMPOSITION AGAINST HUMAN GASTRIN 17 | |
WO1990007321A3 (en) | Lymphocyte receptor homing sequences and their uses | |
WO1998058957A3 (en) | Disulfide cross-linked glycoprotein hormone analogs, their preparation and use | |
TR199700834T1 (en) | 1-Aryl-2-Acylamino ethane compounds and their use as neurokinin, particularly as neurokinin 1 antagonists. | |
EP1757616A3 (en) | Semaphorin receptors | |
EP0228192A3 (en) | Renin-inhibitory oligopeptides, their preparation and use | |
EP1005539A4 (en) | IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS | |
AU3927189A (en) | N-2,3-butadienyl tri- and tetraaminoalkane derivatives | |
AU3526689A (en) | Peptides that block the binding of hiv-1 to the cd4 receptor protein | |
DE68914700T2 (en) | Polymer compositions and their preparation. | |
IL110585A0 (en) | Tripeptides, their preparation and pharmaceutical compositions containing them | |
EP0344979A3 (en) | Alfa-adrenergic receptor antagonists | |
WO1999012945A3 (en) | Hydrophobic glycosylamine derivatives, compositions, and methods for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PAT.BUL.16/90,UNDER INID (54) TITLE REPLACE THE EXISTING TEXT BY "LYMPHOCYTE RECEPTOR HOMING SEQUENCES AND THEIR USES" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1990902104 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1990902104 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1990902104 Country of ref document: EP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |